## Distinguishing Seropositive from Seronegative RA **Key Point:** The defining difference between seropositive and seronegative RA is the presence or absence of circulating autoantibodies, specifically rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibodies. ### Serological Markers | Feature | Seropositive RA | Seronegative RA | |---------|-----------------|------------------| | **Rheumatoid Factor** | Present (>80% of cases) | Absent | | **Anti-CCP Antibodies** | Present (>95% of cases) | Absent | | **Disease Severity** | More aggressive, worse prognosis | Generally milder | | **Erosive Changes** | Earlier and more extensive | Slower progression | | **Extra-articular Manifestations** | More common | Less common | **High-Yield:** Anti-CCP antibodies are more specific for RA than RF and can predict disease development even before clinical symptoms appear. They are present in ~95% of seropositive RA cases. ### Clinical Similarities (NOT Discriminators) Both seropositive and seronegative RA share: - Symmetric polyarticular involvement (small joints of hands and feet) - Pannus formation and joint destruction - Morning stiffness and inflammatory symptoms - Similar histopathological changes (synovitis, pannus) **Clinical Pearl:** Seronegative RA accounts for ~20-30% of RA cases. While generally less severe, some seronegative patients can develop erosive disease and require aggressive treatment. **Warning:** Do not confuse the presence of joint inflammation or pannus formation as discriminators—these occur in both seropositive and seronegative RA. The serological status is the defining criterion. [cite:Robbins 10e Ch 6]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.